Clinical Trial Update: Evaluation of Psilocybin in Anorexia Nervosa: Safety and Efficacy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating psilocybin for safety and efficacy in anorexia nervosa has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anorexia Nervosa

Drugs mentioned

• Psilocybin (psilocybin)

Snippet

Sponsor: University of California, San Diego | Conditions: Anorexia Nervosa | Phase 2 | Status: COMPLETED